The role of hydroxyurea in enhancing the virologic control achieved through structured treatment interruption in primary HIV infection : Final results from a randomized clinical trial (Pulse)
- Author
- BLOCK, Mark T1 ; MED, M1 ; FINLAYSON, Robert J4 ; MCFARLANE, Robert5 ; KELLEHER, Anthony D2 3 ; CARR, Andrew6 ; COOPER, David A2 6 ; SMITH, Don E2 ; QUAN, Dick1 ; KALDOR, John M2 ; ZAUNDERS, John J3 ; PETOUMENOS, Kafhy2 ; IRVINE, Kathy2 ; LAW, Matthew2 ; GREY, Pat2
[1] Holdsworth House Medical Practice, Australia
[2] National Centre in HIV Epidemiology and Clinical Research, UNSW, Australia
[3] Centre for Immunology, St. Vincent's Hospital, Australia
[4] Taylor Square Private Clinic, Australia
[5] 407 Doctors, Australia
[6] St Vincent's Hospital, Sydney, New South Wales, Australia - Source
Journal of acquired immune deficiency syndromes (1999). 2006, Vol 42, Num 2, pp 192-202, 11 p ; ref : 57 ref
- ISSN
- 1525-4135
- Scientific domain
- Immunology, immunopathology, allergology; Virology
- Publisher
- Lippincott Williams & Wilkins, Hagerstown, MD
- Publication country
- United States
- Document type
- Article
- Language
- English
- Author keyword
- hydroxyurea primary HIV infection randomized clinical trial therapy treatment interruption
- Keyword (fr)
- Essai clinique Hydroxycarbamide Microbiologie Primoinfection SIDA Traitement Virologie Immunodéficit Immunopathologie Infection Virose
- Keyword (en)
- Clinical trial Hydroxycarbamide Microbiology Primary infection AIDS Treatment Virology Immune deficiency Immunopathology Infection Viral disease
- Keyword (es)
- Ensayo clínico Hidroxicarbamida Microbiología Primoinfección SIDA Tratamiento Virología Inmunodeficiencia Inmunopatología Infección Virosis
- Classification
- Pascal
- 002 Biological and medical sciences / 002A Fundamental and applied biological sciences. Psychology / 002A05 Microbiology / 002A05C Virology / 002A05C10 Miscellaneous
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B05 Infectious diseases / 002B05C Viral diseases / 002B05C02 Human viral diseases / 002B05C02D Viral diseases of the lymphoid tissue and the blood. Aids
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B05 Infectious diseases / 002B05C Viral diseases / 002B05C02 Human viral diseases / 002B05C02J Miscellaneous
- Discipline
- Infectious pathology Microbiology
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 17838280
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1097/01.qai.0000219779.50668.e6 
https://dx.doi.org/10.1097/01.qai.0000219779.50668.e6
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:34:\"10.1097\/01.qai.0000219779.50668.e6\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:191:\"The role of hydroxyurea in enhancing the virologic control achieved through structured treatment interruption in primary HIV infection : Final results from a randomized clinical trial (Pulse)\";s:9:\"\u0000*\u0000jtitle\";s:54:\"Journal of acquired immune deficiency syndromes (1999)\";s:9:\"\u0000*\u0000stitle\";s:38:\"J. acquir. immune defic. syndr. (1999)\";s:7:\"\u0000*\u0000date\";s:4:\"2006\";s:9:\"\u0000*\u0000volume\";s:2:\"42\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:3:\"192\";s:8:\"\u0000*\u0000epage\";s:3:\"202\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1525-4135\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"BLOCK\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Mark T\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:14:{i:0;s:6:\"MED, M\";i:1;s:19:\"FINLAYSON, Robert J\";i:2;s:17:\"MCFARLANE, Robert\";i:3;s:19:\"KELLEHER, Anthony D\";i:4;s:12:\"CARR, Andrew\";i:5;s:15:\"COOPER, David A\";i:6;s:12:\"SMITH, Don E\";i:7;s:10:\"QUAN, Dick\";i:8;s:14:\"KALDOR, John M\";i:9;s:16:\"ZAUNDERS, John J\";i:10;s:17:\"PETOUMENOS, Kafhy\";i:11;s:13:\"IRVINE, Kathy\";i:12;s:12:\"LAW, Matthew\";i:13;s:9:\"GREY, Pat\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:191:\"The role of hydroxyurea in enhancing the virologic control achieved through structured treatment interruption in primary HIV infection : Final results from a randomized clinical trial (Pulse)\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"11\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:34:\"10.1097\/01.qai.0000219779.50668.e6\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:191:\"The role of hydroxyurea in enhancing the virologic control achieved through structured treatment interruption in primary HIV infection : Final results from a randomized clinical trial (Pulse)\";s:9:\"\u0000*\u0000jtitle\";s:54:\"Journal of acquired immune deficiency syndromes (1999)\";s:9:\"\u0000*\u0000stitle\";s:38:\"J. acquir. immune defic. syndr. (1999)\";s:7:\"\u0000*\u0000date\";s:4:\"2006\";s:9:\"\u0000*\u0000volume\";s:2:\"42\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:3:\"192\";s:8:\"\u0000*\u0000epage\";s:3:\"202\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1525-4135\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"BLOCK\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Mark T\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:14:{i:0;s:6:\"MED, M\";i:1;s:19:\"FINLAYSON, Robert J\";i:2;s:17:\"MCFARLANE, Robert\";i:3;s:19:\"KELLEHER, Anthony D\";i:4;s:12:\"CARR, Andrew\";i:5;s:15:\"COOPER, David A\";i:6;s:12:\"SMITH, Don E\";i:7;s:10:\"QUAN, Dick\";i:8;s:14:\"KALDOR, John M\";i:9;s:16:\"ZAUNDERS, John J\";i:10;s:17:\"PETOUMENOS, Kafhy\";i:11;s:13:\"IRVINE, Kathy\";i:12;s:12:\"LAW, Matthew\";i:13;s:9:\"GREY, Pat\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:191:\"The role of hydroxyurea in enhancing the virologic control achieved through structured treatment interruption in primary HIV infection : Final results from a randomized clinical trial (Pulse)\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"11\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:34:\"10.1097\/01.qai.0000219779.50668.e6\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:34:\"10.1097\/01.qai.0000219779.50668.e6\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:191:\"The role of hydroxyurea in enhancing the virologic control achieved through structured treatment interruption in primary HIV infection : Final results from a randomized clinical trial (Pulse)\";s:9:\"\u0000*\u0000jtitle\";s:54:\"Journal of acquired immune deficiency syndromes (1999)\";s:9:\"\u0000*\u0000stitle\";s:38:\"J. acquir. immune defic. syndr. (1999)\";s:7:\"\u0000*\u0000date\";s:4:\"2006\";s:9:\"\u0000*\u0000volume\";s:2:\"42\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:3:\"192\";s:8:\"\u0000*\u0000epage\";s:3:\"202\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1525-4135\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"BLOCK\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Mark T\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:14:{i:0;s:6:\"MED, M\";i:1;s:19:\"FINLAYSON, Robert J\";i:2;s:17:\"MCFARLANE, Robert\";i:3;s:19:\"KELLEHER, Anthony D\";i:4;s:12:\"CARR, Andrew\";i:5;s:15:\"COOPER, David A\";i:6;s:12:\"SMITH, Don E\";i:7;s:10:\"QUAN, Dick\";i:8;s:14:\"KALDOR, John M\";i:9;s:16:\"ZAUNDERS, John J\";i:10;s:17:\"PETOUMENOS, Kafhy\";i:11;s:13:\"IRVINE, Kathy\";i:12;s:12:\"LAW, Matthew\";i:13;s:9:\"GREY, Pat\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:191:\"The role of hydroxyurea in enhancing the virologic control achieved through structured treatment interruption in primary HIV infection : Final results from a randomized clinical trial (Pulse)\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"11\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:34:\"10.1097\/01.qai.0000219779.50668.e6\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:191:\"The role of hydroxyurea in enhancing the virologic control achieved through structured treatment interruption in primary HIV infection : Final results from a randomized clinical trial (Pulse)\";s:9:\"\u0000*\u0000jtitle\";s:54:\"Journal of acquired immune deficiency syndromes (1999)\";s:9:\"\u0000*\u0000stitle\";s:38:\"J. acquir. immune defic. syndr. (1999)\";s:7:\"\u0000*\u0000date\";s:4:\"2006\";s:9:\"\u0000*\u0000volume\";s:2:\"42\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:3:\"192\";s:8:\"\u0000*\u0000epage\";s:3:\"202\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1525-4135\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"BLOCK\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Mark T\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:14:{i:0;s:6:\"MED, M\";i:1;s:19:\"FINLAYSON, Robert J\";i:2;s:17:\"MCFARLANE, Robert\";i:3;s:19:\"KELLEHER, Anthony D\";i:4;s:12:\"CARR, Andrew\";i:5;s:15:\"COOPER, David A\";i:6;s:12:\"SMITH, Don E\";i:7;s:10:\"QUAN, Dick\";i:8;s:14:\"KALDOR, John M\";i:9;s:16:\"ZAUNDERS, John J\";i:10;s:17:\"PETOUMENOS, Kafhy\";i:11;s:13:\"IRVINE, Kathy\";i:12;s:12:\"LAW, Matthew\";i:13;s:9:\"GREY, Pat\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:191:\"The role of hydroxyurea in enhancing the virologic control achieved through structured treatment interruption in primary HIV infection : Final results from a randomized clinical trial (Pulse)\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"11\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:34:\"10.1097\/01.qai.0000219779.50668.e6\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:191:\"The role of hydroxyurea in enhancing the virologic control achieved through structured treatment interruption in primary HIV infection : Final results from a randomized clinical trial (Pulse)\";s:9:\"\u0000*\u0000jtitle\";s:54:\"Journal of acquired immune deficiency syndromes (1999)\";s:9:\"\u0000*\u0000stitle\";s:38:\"J. acquir. immune defic. syndr. (1999)\";s:7:\"\u0000*\u0000date\";s:4:\"2006\";s:9:\"\u0000*\u0000volume\";s:2:\"42\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:3:\"192\";s:8:\"\u0000*\u0000epage\";s:3:\"202\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1525-4135\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"BLOCK\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Mark T\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:14:{i:0;s:6:\"MED, M\";i:1;s:19:\"FINLAYSON, Robert J\";i:2;s:17:\"MCFARLANE, Robert\";i:3;s:19:\"KELLEHER, Anthony D\";i:4;s:12:\"CARR, Andrew\";i:5;s:15:\"COOPER, David A\";i:6;s:12:\"SMITH, Don E\";i:7;s:10:\"QUAN, Dick\";i:8;s:14:\"KALDOR, John M\";i:9;s:16:\"ZAUNDERS, John J\";i:10;s:17:\"PETOUMENOS, Kafhy\";i:11;s:13:\"IRVINE, Kathy\";i:12;s:12:\"LAW, Matthew\";i:13;s:9:\"GREY, Pat\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:191:\"The role of hydroxyurea in enhancing the virologic control achieved through structured treatment interruption in primary HIV infection : Final results from a randomized clinical trial (Pulse)\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"11\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
